The molecular constituents of FECR1/FLI1/TET1 employ a feedback loop to stimulate this through promoting DNA hypomethylation in the CpG islands of the promoter, ultimately controlling the metastasis of breast cancer (BC) cells (Figure 1a). Here, FLI1 is linked to breast cancer.